Effect of Membrane Composition on Cytokine Production and Clinical Symptoms During Hemodialysis: A Crossover Study

References

• Lipps B., Stewart R., Perkins H. The hollow fiber artificial kidney. Trans. Am. Soc. Artif. Intern. Organs 1967; 13: 200–207
   Google Scholar
• Walton D., Cheung A. Membrane biocompatibility. Clinical Dialysis 3, A. Nissenson, R. Fine, D. Gentile, C.T. Norwalk. Appleton and Lange. 1995; 93–120
   Google Scholar
• Colton CK. Analysis of membrane processes for blood purification. Blood Purif. 1987; 5(4)202–251
   Google Scholar
• Henderson L.W., Koch K.M., Dinarello C.A., Shaldon S. Hemodialysis hypotension the interleukin hypothesis. Blood Purif. 1983; 1: 3–8
   Google Scholar
• Gesualdo L., Pertosa G., Grandaliano G., Schena F.P. Cytokines and bioincompatibility. Nephrol. Dial. Transplant. 1998; 13(7)1622–1626
   Google Scholar
• Jorres A., Froese P., Fischer C., Safak H., Gahl G.M., Muller C., Vienken J. Variables associated with the assessment of systemic tumor necrosis factor alpha levels during hemodialysis. Int. J. Artif. Organs 1992; 15(11)653–657
   Google Scholar
• Pollak V.E., Charoenpanich R., Robson M., Kant K.S. Dialyzer membranes: syndromes associated with first use and effects of multiple use. Kidney Int. suppl. 1988; 24: S49–S52
   Google Scholar
• Hakim R.M. Influence of the dialysis membrane on outcome of ESRD patients. Am. J. Kidney Dis. 1998; 32(6 suppl 4)S71–75
   Google Scholar
• Klinkmann H., Vienken J. Membranes for dialysis. Nephrol. Dial. Transplant. 1995; 10(suppl 3)39–45
   Google Scholar
• Gardinali M., Calcagno A., Conciato L., Agostoni A., Rosti A., Cori P., Vozzo N., Moroni A., Anelli A., Zoni U. Complement activation in dialysis: effects on cytokines, lymphocyte activation and beta 2 microglobulin. Int. J. Artif. Organs 1994; 17(6)337–344
   Google Scholar
• Dunati D., Degiannis D., Homer L., Raska K., Jr., Roskova J. Production and kinetics of interleukin-1 in hemodialysis. In vivo and in vitro study. Am. J. Nephrol. 1991; 11(6)451–458
   Google Scholar
• Herbelin A., Urena P., Nguyen A.T., Zingraff J., Descamps-Latscha B. Influence of first and long term dialysis on uremia associated increased basal production of interleukin-1 and tumour necrosis factor alpha by circulating monocytes. Nephrol. Dial. Transplant 1991; 6(5)349–357
   Google Scholar
• Herbelin A., Nguyen A.T., Zingraff J., Urena P., Deschamps-Latsha B. Influence of uremia and hemodialysis on circulating interleukin-1 and tumour necrosis factor alpha. Kidney Int. 1990; 37: 116–125
   Google Scholar
• Pereira B.J., Poutsiaka D.D., King A.J., Strom J.A., Narayan G., Levey A.S., Dinarello C.A. In vitro production of interleukin-1 receptor antagonists in chronic renal failure: CAPD and HD. Kidney Int. 1992; 42(6)1419–1424
   Google Scholar
• Powell A.C., Bland L.A., Oettinger C.W., McAllister S.K., Oliver J.C., Arduino M.J., Favero M.S. Enhanced release of TNF alpha but not IL-1beta from uremic blood after endotoxin stimulation. Lymphokine Cytokine Res. 1991; 10(5)343–346
   Google Scholar
• Homes C., Evans R., Ross D., Frankamp P. Plasma interleukin-1 and tumour necrosis factor levels during high flux dialysis with cellulose triacetate membranes (abstract). Kidney Int. 1990; 37: 301
   Google Scholar
• Powell A.C., Bland L., Oettinger C.W. Plasma interleukin-1 beta and tumour necrosis factor alpha do not increase during unfavorable dialysis conditions (abstract). J. Am. Sol. Nephrol. 1990; 1: 373
   Google Scholar
• Mege J.L., Olmer M., Purgus R., Bertocchio P., Farnarier C., Kaplanski S., Capo C., Bongrand P. Hemodialysis membranes modulate chronically the production of TNF alpha, IL-1beta, and IL6. Nephrol. Dial. Transplant. 1991; 6(11)868–875
   Google Scholar
• Chollet-Martin S., Stamatakis G., Bailly S., Mery J.P., Gougerot-Pocidalo M.A. Induction of tumor necrosis factor alpha during hemodialysis. Influence of membrane type. Clin. Exp. Immunol. 1991; 83(2)329–332
   Google Scholar
• Davenport A., Crabtree J., Androjna C., Will E.J., Davison A.M. Tumour necosis factor does not increase during routine cuprophane haemodialysis in healthy well nourished patients. Nephrol. Dial. Transplant. 1991; 6(6)435–439
   Google Scholar
• Mandolfo S., Tetta C., David S., Gervasio R., Ognibene D., Wratten M.L., Tessore E., Imbasciati E. In vitro and in vivo biocompatibility of substituted cellulose and synthetic membranes. Int. J. Artif. Organs 1997; 20(11)603–609
   Google Scholar
• McLaughlin P.J., Davies H.M., Aikawa A. Tumour necrosis factor in normal plasma. Lancet 1990; 336(8721)1014–1015
   Google Scholar
• Haeffner-Cavaillon N., Cavaillon J.M., Ciancioni C., Bacle F., Delons S., Kazatchkine M.D. In vivo induction of interleukin-1 during hemodialysis. Kidney Int. 1989; 35(5)1212–1218
   Google Scholar
• Dinarello C.A. Cytokines: agents provocateurs in hemodialysis?. Kidney Int. 1992; 41(3)683–694
   Google Scholar
• Zaoui P., Hakim R.M. The effects of the dialysis membrane on cytokine release. J. Am. Soc. Nephrol. 1994; 4(9)1711–1718
   Google Scholar
• Goldfarb S., Golper T. Proinflammatory cytokines and hemofiltration membranes. J. Am. Soc. Nephrol. 1994; 5(2)228–232
   Google Scholar
• Jorstad S. Biocompatibility of different hemodialysis and plasmapheresis membranes. Blood Purif. 1987; 5(2–3)123–137
   Google Scholar
• Chanard J., Brunois J.P., Melin J.P., Lavaud S., Toupance O. Long term results of dialysis therapy with a highly permeable membrane. Artif. Organs 1982; 6: 261–266
   Google Scholar
• Locatelli F., Mastrangelo F., Redaelli B., Ronco C., Marcelli D., LaGreca G., Orlandini G. Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group. Kidney Int. 1996; 50(4)1293–1302
   Google Scholar
• Bergamo Collaborative Dialysis Study Group. Acute Intradialytic well-being: results of a clinical trial comparing polysulfone with cuprophan. Kidney Int. 1991; 40(4)714–719
   Google Scholar
• Skroeder N.R., Jacobson S.H., Lins L.E., Kjellstrand C.M. Biocompatibility of dialysis membranes is of no importance for objective or subjective symptoms during or after hemodialysis. ASAIO Trans. 1990; 36: M637–M639
   Google Scholar
• Collins D.M., Lambert M.B., Tannenbaum J.S., Oliverio M., Schwab S.J. Tolerance of hemodialysis: a randomized prospective trial of high flux versus conventional high efficiency hemodialysis. J. Am. Soc. Nephrol. 1993; 4(2)148–154
   Google Scholar
• Salem M., Ivanovich P.T., Ing T.S., Dougirdas J.T. Adverse effects of dialyzers manifesting during the dialysis session. Nephrol. Dial. Transplant. 1994; 9(suppl 2)127–137
   Google Scholar
• Orofino L., Marcen R., Quereda C., Villefruela J.J., Sabater J., Matesanz R., Pascual J., Ortuno J. Epidemiology of symptomatic hypotension in hemodialysis: is cool dialysate beneficial for all patients? Am. J. Nephrol. 1990; 10: 177–180
   Google Scholar
• Cappelli G., DiFelice A., Perrone S., Ballestri M., Bonucchi D., Savazzi A.M., Guffreda A., Lusvarghi E. Which level of cytokine production is critical in hemodialysis? Nephrol. Dial. Transplant. 1998; 13(suppl 7)55–60
   Google Scholar